These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27610390)

  • 61. Effect of filarial infection on serum inflammatory and atherogenic biomarkers in coronary artery disease (CURES-121).
    Aravindhan V; Mohan V; Surendar J; Rao MM; Anuradha R; Deepa M; Babu S
    Am J Trop Med Hyg; 2012 May; 86(5):828-33. PubMed ID: 22556082
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased levels of serum granulocyte-macrophage colony-stimulating factor is associated with activated peripheral dendritic cells in type 2 diabetes subjects (CURES-99).
    Surendar J; Mohan V; Pavankumar N; Babu S; Aravindhan V
    Diabetes Technol Ther; 2012 Apr; 14(4):344-9. PubMed ID: 22149626
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4.
    Chang YH; Ho KT; Lu SH; Huang CN; Shiau MY
    Int J Obes (Lond); 2012 Jul; 36(7):993-8. PubMed ID: 21894160
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP-PAMP complexes.
    Pisetsky D
    Swiss Med Wkly; 2011; 141():w13256. PubMed ID: 21877298
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of IL-33 in inflammation and disease.
    Miller AM
    J Inflamm (Lond); 2011 Aug; 8(1):22. PubMed ID: 21871091
    [TBL] [Abstract][Full Text] [Related]  

  • 66. NOD1 activators link innate immunity to insulin resistance.
    Schertzer JD; Tamrakar AK; Magalhães JG; Pereira S; Bilan PJ; Fullerton MD; Liu Z; Steinberg GR; Giacca A; Philpott DJ; Klip A
    Diabetes; 2011 Sep; 60(9):2206-15. PubMed ID: 21715553
    [TBL] [Abstract][Full Text] [Related]  

  • 67. NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3-L1 adipocytes.
    Zhao L; Hu P; Zhou Y; Purohit J; Hwang D
    Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E587-98. PubMed ID: 21693690
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Activation of type I IFN signaling by NOD1 mediates mucosal host defense against Helicobacter pylori infection.
    Watanabe T; Asano N; Kitani A; Fuss IJ; Chiba T; Strober W
    Gut Microbes; 2011; 2(1):61-5. PubMed ID: 21637021
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunometabolism: an emerging frontier.
    Mathis D; Shoelson SE
    Nat Rev Immunol; 2011 Feb; 11(2):81. PubMed ID: 21469396
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation.
    Louten J; Rankin AL; Li Y; Murphy EE; Beaumont M; Moon C; Bourne P; McClanahan TK; Pflanz S; de Waal Malefyt R
    Int Immunol; 2011 May; 23(5):307-15. PubMed ID: 21422152
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Leaky gut and diabetes mellitus: what is the link?
    de Kort S; Keszthelyi D; Masclee AA
    Obes Rev; 2011 Jun; 12(6):449-58. PubMed ID: 21382153
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome (CURES-103).
    Surendar J; Mohan V; Rao MM; Babu S; Aravindhan V
    Diabetes Technol Ther; 2011 Apr; 13(4):477-82. PubMed ID: 21355722
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nod1 ligands induce site-specific vascular inflammation.
    Nishio H; Kanno S; Onoyama S; Ikeda K; Tanaka T; Kusuhara K; Fujimoto Y; Fukase K; Sueishi K; Hara T
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1093-9. PubMed ID: 21330608
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Th9: a new player in asthma pathogenesis?
    Xing J; Wu Y; Ni B
    J Asthma; 2011 Mar; 48(2):115-25. PubMed ID: 21294663
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increased expression of macrophage-inducible C-type lectin in adipose tissue of obese mice and humans.
    Ichioka M; Suganami T; Tsuda N; Shirakawa I; Hirata Y; Satoh-Asahara N; Shimoda Y; Tanaka M; Kim-Saijo M; Miyamoto Y; Kamei Y; Sata M; Ogawa Y
    Diabetes; 2011 Mar; 60(3):819-26. PubMed ID: 21282371
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability.
    Erbel C; Dengler TJ; Wangler S; Lasitschka F; Bea F; Wambsganss N; Hakimi M; Böckler D; Katus HA; Gleissner CA
    Basic Res Cardiol; 2011 Jan; 106(1):125-34. PubMed ID: 21116822
    [TBL] [Abstract][Full Text] [Related]  

  • 77. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk.
    Brown J; Wang H; Hajishengallis GN; Martin M
    J Dent Res; 2011 Apr; 90(4):417-27. PubMed ID: 20940366
    [TBL] [Abstract][Full Text] [Related]  

  • 78. NOD2 activation induces muscle cell-autonomous innate immune responses and insulin resistance.
    Tamrakar AK; Schertzer JD; Chiu TT; Foley KP; Bilan PJ; Philpott DJ; Klip A
    Endocrinology; 2010 Dec; 151(12):5624-37. PubMed ID: 20926588
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Decreased serum interleukin-17 and increased transforming growth factor-β levels in subjects with metabolic syndrome (Chennai Urban Rural Epidemiology Study-95).
    Surendar J; Aravindhan V; Rao MM; Ganesan A; Mohan V
    Metabolism; 2011 Apr; 60(4):586-90. PubMed ID: 20667562
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk.
    Manco M; Putignani L; Bottazzo GF
    Endocr Rev; 2010 Dec; 31(6):817-44. PubMed ID: 20592272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.